Vern Norviel
Corporate Officer/Principal chez Wilson Sonsini Goodrich & Rosati PC
Profil
Vern Norviel is the founder of Neuvivo, Inc. He currently holds the position of Partner at Wilson Sonsini Goodrich & Rosati PC and Special Advisor at Apple Tree Venture Management LLC.
Previously, he worked as General Counsel at Perlegen Sciences, Inc. and Partner at Townsend & Associates, Inc. Mr. Norviel has a graduate degree from Santa Clara University and the University of San Francisco School of Law, and an undergraduate degree from the University of Colorado Boulder.
Postes actifs de Vern Norviel
| Sociétés | Poste | Début |
|---|---|---|
Wilson Sonsini Goodrich & Rosati PC
 Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Consultant / Advisor | - |
Anciens postes connus de Vern Norviel
| Sociétés | Poste | Fin |
|---|---|---|
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Conseiller Juridique Général | 12/02/2020 |
Townsend & Associates, Inc.
 Townsend & Associates, Inc. Investment ManagersFinance Townsend & Associates, Inc. (Townsend) is an independent, privately owned SEC-registered investment advisor headquartered in Westminster, Colorado. The firm was founded by Jeffery E. Townsend in 1990. Townsend provides investment advice to individual and institutional clients. | Private Equity Investor | 01/01/1994 |
Neuvivo, Inc.
 Neuvivo, Inc. Pharmaceuticals: MajorHealth Technology Neuvivo, Inc. is a biopharmaceutical company based in an undisclosed location. Neuvivo is dedicated to developing new treatments for ALS and other neurodegenerative diseases. The American company's lead candidate, NP001, has shown promise in treating ALS with an excellent safety profile. Neuvivo is working to make this treatment broadly available to patients and is dedicated to stopping ALS progression by transforming inflammatory macrophages to control the progression of motor neuron damage. The company was founded by industry leaders and scientists, including Michael S. McGrath, Ari Azhir, and Vern Norviel. Ari Azhir has been the CEO since incorporation. | Fondateur | - |
Formation de Vern Norviel
| Santa Clara University | Graduate Degree |
| University of Colorado Boulder | Undergraduate Degree |
| University of San Francisco School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Perlegen Sciences, Inc.
Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Retail Trade |
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Commercial Services |
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Finance |
Townsend & Associates, Inc.
Townsend & Associates, Inc. Investment ManagersFinance Townsend & Associates, Inc. (Townsend) is an independent, privately owned SEC-registered investment advisor headquartered in Westminster, Colorado. The firm was founded by Jeffery E. Townsend in 1990. Townsend provides investment advice to individual and institutional clients. | Finance |
Neuvivo, Inc.
Neuvivo, Inc. Pharmaceuticals: MajorHealth Technology Neuvivo, Inc. is a biopharmaceutical company based in an undisclosed location. Neuvivo is dedicated to developing new treatments for ALS and other neurodegenerative diseases. The American company's lead candidate, NP001, has shown promise in treating ALS with an excellent safety profile. Neuvivo is working to make this treatment broadly available to patients and is dedicated to stopping ALS progression by transforming inflammatory macrophages to control the progression of motor neuron damage. The company was founded by industry leaders and scientists, including Michael S. McGrath, Ari Azhir, and Vern Norviel. Ari Azhir has been the CEO since incorporation. | Health Technology |
